Reactive nitrogen species as therapeutic targets for autophagy: implication for ischemic stroke

Expert Opinion on Therapeutic Targets

Volumn 21, Issue 3, 2017, Pages 305-317

  Feng, Jinghan ^a,b   Chen, Xingmiao ^a,b   Shen, Jiangang ^a,b  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (China)

Author keywords

Autophagy; ischemic stroke; mitochondria; mitophagy; programmed cell death; reactive nitrogen species

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 METHYLADENINE; BAFILOMYCIN A1; CHLOROQUINE; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; REACTIVE NITROGEN SPECIES; WORTMANNIN;

AUTOPHAGOSOME; AUTOPHAGY; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; DRUG ADMINISTRATION ROUTE; DRUG CONCENTRATION; HUMAN; MITOCHONDRION; MITOPHAGY; NONHUMAN; REPERFUSION INJURY; REVIEW; SELECTIVE AUTOPHAGY; ANIMAL; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; DRUG DESIGN; DRUG EFFECTS; FIBRINOLYTIC THERAPY; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; PROCEDURES;

ANIMALS; AUTOPHAGY; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DRUG DESIGN; HUMANS; MITOCHONDRIAL DEGRADATION; MOLECULAR TARGETED THERAPY; REACTIVE NITROGEN SPECIES; REPERFUSION INJURY; STROKE; THROMBOLYTIC THERAPY;

EID: 85013027014     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1080/14728222.2017.1281250     Document Type: Review

References (176)

1. Boya P, Reggiori F, Codogno P., Emerging regulation and functions of autophagy. Nat Cell Biol. 2013 Jul;15(7):713–720.
2. Ohsumi Y. Historical landmarks of autophagy research. Cell Res. 2014 Jan;24(1):9–23.•• Panoramic historical review on the autophagy research.
3. Galluzzi L, Pietrocola F, Levine B, et al. Metabolic control of autophagy. Cell. 2014 Dec 4;159(6):1263–1276.
4. Gallagher LE, Williamson LE, Ey C. Advances in autophagy regulatory mechanisms. Cells. 2016;5:2.
5. Nikoletopoulou V, Papandreou ME, Tavernarakis N. Autophagy in the physiology and pathology of the central nervous system. Cell Death Differ. 2015 Mar;22(3):398–407.
6. Yamamoto A, Yue Z. Autophagy and its normal and pathogenic states in the brain. Annu Rev Neurosci. 2014;37:55–78.
7. Liu H, Qiu H, Xiao Q, et al. Chronic hypoxia-induced autophagy aggravates the neuropathology of Alzheimer’s Disease through AMPK-mTOR signaling in the APPSwe/PS1dE9 mouse model. J Alzheimers Dis. 2015;48(4):1019–1032.
8. Pan T, Kondo S, Le W, et al. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson’s disease. Brain. 2008 Aug;131(Pt 8):1969–1978.
9. Martin DD, Ladha S, Ehrnhoefer DE, et al. Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci. 2015 Jan;38(1):26–35.
10. Chen S, Zhang X, Song L, et al. Autophagy dysregulation in amyotrophic lateral sclerosis. Brain Pathol. 2012 Jan;22(1):110–116.
11. Menzies FM, Fleming A, Rubinsztein DC. Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci. 2015 Jun;16(6):345–357.
12. Tan CC, Yu JT, Tan MS, et al. Autophagy in aging and neurodegenerative diseases:implications for pathogenesis and therapy. Neurobiol Aging. 2014 May;35(5):941–957.
13. Huang Z, Adachi H. Natural compounds preventing neurodegenerative diseases through autophagic activation. J Uoeh. 2016 Jun 1;38(2):139–148.
14. Wu H, Niu H, Wu C, et al. The autophagy-lysosomal system in subarachnoid haemorrhage. J Cell Mol Med. 2016 Sep;20(9):1770-1778.
15. Liang K, Zhu L, Tan J, et al. Identification of autophagy signaling network that contributes to stroke in the ischemic rodent brain via gene expression. Neurosci Bull. 2015 Aug;31(4):480–490.
16. Mizushima N, Komatsu M. Autophagy renovation of cells and tissues. Cell. 2011 Nov 11;147(4):728–741.
17. Wei K, Wang P, Miao CY. A double-edged sword with therapeutic potential:an updated role of autophagy in ischemic cerebral injury. CNS Neurosci Ther. 2012 Nov;18(11):879–886.• Review of the dual roles of autophagy in ischemic stroke.
18. Zheng Y, Hou J, Liu J, et al. Inhibition of autophagy contributes to melatonin-mediated neuroprotection against transient focal cerebral ischemia in rats. J Pharmacol Sci. 2014;124(3):354–364.
19. Liu C, Gao Y, Barrett J, et al. Autophagy and protein aggregation after brain ischemia. J Neurochem. 2010 Oct;115(1):68–78.
20. Martinet W, Timmermans JP, De Meyer GR. Methods to assess autophagy in situ–transmission electron microscopy versus immunohistochemistry. Methods Enzymol. 2014;543:89–114.
21. Chen W, Sun Y, Liu K, et al. Autophagy:a double-edged sword for neuronal survival after cerebral ischemia. Neural Regen Res. 2014 Jun 15;9(12):1210–1216.
22. Redmann M, Darley-Usmar V, Zhang J. The role of autophagy, mitophagy and lysosomal functions in modulating bioenergetics and survival in the context of redox and proteotoxic damage:implications for neurodegenerative diseases. Aging Dis. 2016 Mar;7(2):150–162.
23. Kim A. A panoramic overview of mitochondria and mitochondrial redox biology. Toxicol Res. 2014 Dec;30(4):221–234.
24. Kang J, Pervaiz S. Mitochondria:redox metabolism and dysfunction. Biochem Res Int. 2012;2012:896751.
25. Chen XM, Chen HS, Xu MJ, et al. Targeting reactive nitrogen species:a promising therapeutic strategy for cerebral ischemia-reperfusion injury. Acta Pharmacol Sin. 2013 Jan;34(1):67–77.•• Extensive review on the roles of reactive nitrogen species in cerebral ischemia-reperfusion injury.
26. Scherz-Shouval R, Elazar Z. Regulation of autophagy by ROS:physiology and pathology. Trends Biochem Sci. 2011 Jan;36(1):30–38.
27. Lu Q, Harris VA, Kumar S, et al. Autophagy in neonatal hypoxia ischemic brain is associated with oxidative stress. Redox Biol. 2015;6:516–523.
28. Pugsley HR. Quantifying autophagy:measuring LC3 puncta and autolysosome formation in cells using multispectral imaging flow cytometry. Methods. 2017 Jan 1;112:147-156.
29. Katsuragi Y, Ichimura Y, Komatsu M. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. Febs J. 2015 Dec;282(24):4672–4678.
30. Komatsu M, Ichimura Y. Physiological significance of selective degradation of p62 by autophagy. FEBS Lett. 2010 Apr 2;584(7):1374–1378.
31. Schlafli AM, Berezowska S, Adams O, et al. Reliable LC3 and p62 autophagy marker detection in formalin fixed paraffin embedded human tissue by immunohistochemistry. Eur J Histochem. 2015;59(2):2481.• LC3 and p62, as autophagy markers, were detected in human tissue by immunohistochemistry.
32. Tian F, Deguchi K, Yamashita T, et al. In vivo imaging of autophagy in a mouse stroke model. Autophagy. 2010 Nov;6(8):1107–1114.
33. Li H, Qiu S, Li X, et al. Autophagy biomarkers in CSF correlates with infarct size, clinical severity and neurological outcome in AIS patients. J Transl Med. 2015;13:359.
34. Frugier T, Taylor JM, McLean C, et al. Evidence for the recruitment of autophagic vesicles in human brain after stroke. Neurochem Int. 2016 Jun;96:62–68.• Autophagic vesicles were observed in human postmortem brain tissue after stroke.
35. Shi R, Weng J, Zhao L, et al. Excessive autophagy contributes to neuron death in cerebral ischemia. CNS Neurosci Ther. 2012 Mar;18(3):250–260.
36. Pan R, Timmins GS, Liu W, et al. Autophagy mediates astrocyte death during zinc-potentiated ischemia–reperfusion injury. Biol Trace Elem Res. 2015 Jul;166(1):89–95.
37. Urbanek T, Kuczmik W, Basta-Kaim A, et al. Rapamycin induces of protective autophagy in vascular endothelial cells exposed to oxygen-glucose deprivation. Brain Res. 2014 Mar;17(1553):1–11.
38. Liu K, Sun Y, Gu Z, et al. Mitophagy in ischaemia/reperfusion induced cerebral injury. Neurochem Res. 2013 Jul;38(7):1295–1300.
39. Kang C, Avery L. To be or not to be, the level of autophagy is the question:dual roles of autophagy in the survival response to starvation. Autophagy. 2008 Jan;4(1):82–84.
40. Gao L, Jiang T, Guo J, et al. Inhibition of autophagy contributes to ischemic postconditioning-induced neuroprotection against focal cerebral ischemia in rats. Plos One. 2012;7(9):e46092.
41. Wang J, Han D, Sun M, et al. A combination of remote ischemic perconditioning and cerebral ischemic postconditioning inhibits autophagy to attenuate plasma HMGB1 and induce neuroprotection against stroke in rat. J Mol Neurosci. 2016 Apr;58(4):424–431.
42. Zhu Y, Bu Q, Liu X, et al. Neuroprotective effect of TAT-14-3-3epsilon fusion protein against cerebral ischemia/reperfusion injury in rats. Plos One. 2014;9(3):e93334.
43. Li L, Tian J, Long MK, et al. Protection against experimental stroke by ganglioside gm1 is associated with the inhibition of autophagy. Plos One. 2016;11(1):e0144219.
44. Qin AP, Liu CF, Qin YY, et al. Autophagy was activated in injured astrocytes and mildly decreased cell survival following glucose and oxygen deprivation and focal cerebral ischemia. Autophagy. 2010 Aug;6(6):738–753.
45. Wen YD, Sheng R, Zhang LS, et al. Neuronal injury in rat model of permanent focal cerebral ischemia is associated with activation of autophagic and lysosomal pathways. Autophagy. 2008 Aug;4(6):762–769.
46. Yang Z, Zhong L, Zhong S, et al. Hypoxia induces microglia autophagy and neural inflammation injury in focal cerebral ischemia model. Exp Mol Pathol. 2015 Apr;98(2):219–224.
47. Wei N, Yu SP, Gu XH, et al. The involvement of autophagy pathway in exaggerated ischemic brain damage in diabetic mice. CNS Neurosci Ther. 2013 Oct;19(10):753–763.
48. Wang JY, Xia Q, Chu KT, et al. Severe global cerebral ischemia-induced programmed necrosis of hippocampal CA1 neurons in rat is prevented by 3-methyladenine:a widely used inhibitor of autophagy. J Neuropathol Exp Neurol. 2011 Apr;70(4):314–322.
49. Jiang Y, Zhu J, Wu L, et al. Tetracycline inhibits local inflammation induced by cerebral ischemia via modulating autophagy. Plos One. 2012;7(11):e48672.
50. Xingyong C, Xicui S, Huanxing S, et al. Upregulation of myeloid cell leukemia-1 potentially modulates beclin-1-dependent autophagy in ischemic stroke in rats. BMC Neurosci. 2013;14:56.
51. Qi Z, Yan F, Shi W, et al. AKT-related autophagy contributes to the neuroprotective efficacy of hydroxysafflor yellow A against ischemic stroke in rats. Transl Stroke Res. 2014 Aug;5(4):501–509.
52. Qi Z, Dong W, Shi W, et al. Bcl-2 phosphorylation triggers autophagy switch and reduces mitochondrial damage in limb remote ischemic conditioned rats after ischemic stroke. Transl Stroke Res. 2015 Jun;6(3):198–206.
53. Li H, Gao A, Feng D, et al. Evaluation of the protective potential of brain microvascular endothelial cell autophagy on blood-brain barrier integrity during experimental cerebral ischemia-reperfusion injury. Transl Stroke Res. 2014 Oct;5(5):618–626.
54. Jiang T, Yu JT, Zhu XC, et al. Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy. Br J Pharmacol. 2014 Jul;171(13):3146–3157.
55. Jiang T, Yu JT, Zhu XC, et al. Ischemic preconditioning provides neuroprotection by induction of AMP-activated protein kinase-dependent autophagy in a rat model of ischemic stroke. Mol Neurobiol. 2015 Feb;51(1):220–229.
56. Sheng R, Zhang LS, Han R, et al. Autophagy activation is associated with neuroprotection in a rat model of focal cerebral ischemic preconditioning. Autophagy. 2010 May;6(4):482–494.
57. Wang P, Xu TY, Wei K, et al. ARRB1/beta-arrestin-1 mediates neuroprotection through coordination of BECN1-dependent autophagy in cerebral ischemia. Autophagy. 2014 Sep;10(9):1535–1548.
58. Buckley KM, Hess DL, Sazonova IY, et al. Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke. Exp Transl Stroke Med. 2014;6:8.
59. Nagelkerke A, Bussink J, Geurts-Moespot A, et al. Therapeutic targeting of autophagy in cancer part II:pharmacological modulation of treatment-induced autophagy. Semin Cancer Biol. 2015 Apr;31:99–105.•• Recent review about pharmacological modulation of autophagy.
60. Zhang Z, Guo M, Zhao S, et al. The update on transcriptional regulation of autophagy in normal and pathologic cells:A novel therapeutic target. Biomed Pharmacother. 2015;74:17–29.
61. Mauvezin C, Neufeld TP. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion. Autophagy. 2015;11(8):1437–1438.
62. Zhou J, Hu SE, Tan SH, et al. Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells. Autophagy. 2012 Mar;8(3):338–349.
63. Seglen PO, Gordon PB. 3-Methyladenine:specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A. 1982 Mar;79(6):1889–1892.
64. Wu YT, Tan HL, Shui G, et al. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem. 2010 Apr 2;285(14):10850–10861.• Report about dual roles of 3-MA in autophagy.
65. Heckmann BL, Yang X, Zhang X, et al. The autophagic inhibitor 3-methyladenine potently stimulates PKA-dependent lipolysis in adipocytes. Br J Pharmacol. 2013 Jan;168(1):163–171.
66. Kim YC, Guan KL. mTOR:a pharmacologic target for autophagy regulation. J Clin Invest. 2015 Jan;125(1):25–32.
67. Ji D, Zhang Z, Cheng L, et al. The combination of RAD001 and MK-2206 exerts synergistic cytotoxic effects against PTEN mutant gastric cancer cells:involvement of MAPK-dependent autophagic, but not apoptotic cell death pathway. Plos One. 2014;9(1):e85116.
68. Rubinfeld H, Cohen O, Kammer A, et al. Combination of mtor inhibitors augments potency while activating PI3K signaling in pituitary tumors. Neuroendocrinology. 2016;103(5):592–604.
69. Zheng XY, Li LJ, Li W, et al. Low concentrations of chloroquine and 3-methyladenine suppress the viability of retinoblastoma cells synergistically with vincristine independent of autophagy inhibition. Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2309–2315.• A good example about different effects of 3-MA on autophagy at different doses.
70. Denton D, Nicolson S, Kumar S. Cell death by autophagy:facts and apparent artefacts. Cell Death Differ. 2012 Jan;19(1):87–95.• Summary about the evidences of autophagic cell death.
71. Galluzzi L, Vitale I, Abrams JM, et al. Molecular definitions of cell death subroutines:recommendations of the nomenclature committee on cell death 2012. Cell Death Differ. 2012 Jan;19(1):107–120.
72. Liu Y, Levine B. Autosis and autophagic cell death:the dark side of autophagy. Cell Death Differ. 2015 Mar;22(3):367–376.• Latest review of the autosis.
73. Liu Y, Shoji-Kawata S, Sumpter RM, Jr., et al. Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20364–20371.
74. Xia M, Meng G, Jiang A, et al. Mitophagy switches cell death from apoptosis to necrosis in NSCLC cells treated with oncolytic measles virus. Oncotarget. 2014 Jun 15;5(11):3907–3918.
75. Yuan J. Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. Apoptosis. 2009 Apr;14(4):469–477.
76. Shen HM, Codogno P. Autophagy is a survival force via suppression of necrotic cell death. Exp Cell Res. 2012 Jul 1;318(11):1304–1308.
77. Xu M, Zhang HL. Death and survival of neuronal and astrocytic cells in ischemic brain injury:a role of autophagy. Acta Pharmacol Sin. 2011 Sep;32(9):1089–1099.
78. Savateev AV, Savateeva-Liubimova TN. [Apoptosis–universal mechanisms of cell death and survival in ischemia and reperfusion:ways to pharmacological control]. Eksp Klin Farmakol. 2010 Dec;73(12):44–49.•• Apoptosis provides therapeutic time window to delay cell death.
79. Fayaz SM, Suvanish Kumar VS, Rajanikant GK. Necroptosis:who knew there were so many interesting ways to die?. CNS Neurol Disord Drug Targets. 2014 Feb;13(1):42–51.
80. Bergsbaken T, Fink SL, Cookson BT. Pyroptosis:host cell death and inflammation. Nat Rev Microbiol. 2009 Feb;7(2):99–109.
81. Speer RE, Karuppagounder SS, Basso M, et al. Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by “antioxidant” metal chelators:from ferroptosis to stroke. Free Radic Biol Med. 2013;62:26–36.
82. Nicotera P, Leist M, Ferrando-May E. Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett. 1998 Dec 28;102-103:139–142.•• A critical role of ATP in the change of different cell death types.
83. Shi RY, Zhu SH, Li V, et al. BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke. CNS Neurosci Ther. 2014 Dec;20(12):1045–1055.
84. Rami A, Kogel D. Apoptosis meets autophagy-like cell death in the ischemic penumbra:two sides of the same coin? Autophagy. 2008 May;4(4):422–426.
85. Dolman NJ, Chambers KM, Mandavilli B, et al. Tools and techniques to measure mitophagy using fluorescence microscopy. Autophagy. 2013 Nov 1;9(11):1653–1662.• Introduction about mitophagy detection under fluorescence microscopy.
86. Ikeda Y, Shirakabe A, Brady C, et al. Molecular mechanisms mediating mitochondrial dynamics and mitophagy and their functional roles in the cardiovascular system. J Mol Cell Cardiol. 2015;78:116–122.
87. Ney PA. Mitochondrial autophagy:origins, significance, and role of BNIP3 and NIX. Biochim Biophys Acta. 2015 Oct;1853(10 Pt B):2775–2783.
88. Choe SC, Hamacher-Brady A, Brady NR. Autophagy capacity and sub-mitochondrial heterogeneity shape Bnip3-induced mitophagy regulation of apoptosis. Cell Commun Signal. 2015;13:37.
89. Liu L, Feng D, Chen G, et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol. 2012 Feb;14(2):177–185.
90. Yamaguchi O, Murakawa T, Nishida K, et al. Receptor-mediated mitophagy. J Mol Cell Cardiol. 2016;95:50–56.
91. Hamacher-Brady A, Brady NR. Mitophagy programs:mechanisms and physiological implications of mitochondrial targeting by autophagy. Cell Mol Life Sci. 2016 Feb;73(4):775–795.• Recent review of mitophagy.
92. Saito T, Sadoshima J. Molecular mechanisms of mitochondrial autophagy/mitophagy in the heart. Circ Res. 2015 Apr 10;116(8):1477–1490.
93. Zhang X, Yan H, Yuan Y, et al. Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance. Autophagy. 2013 Sep;9(9):1321–1333.
94. Yan H, Zhang X, Hu W, et al. Histamine H3 receptors aggravate cerebral ischaemic injury by histamine-independent mechanisms. Nat Commun. 2014;5:3334.
95. Motori E, Puyal J, Toni N, et al. Inflammation-induced alteration of astrocyte mitochondrial dynamics requires autophagy for mitochondrial network maintenance. Cell Metab. 2013 Dec 3;18(6):844–859.
96. Lin C, Chao H, Li Z, et al. Melatonin attenuates traumatic brain injury-induced inflammation:a possible role for mitophagy. J Pineal Res. 2016 Sep;61(2):177–186.
97. Yuan Y, Zhang X, Zheng Y, et al. Regulation of mitophagy in ischemic brain injury. Neurosci Bull. 2015 Aug;31(4):395–406.
98. Li Q, Zhang T, Wang J, et al. Rapamycin attenuates mitochondrial dysfunction via activation of mitophagy in experimental ischemic stroke. Biochem Biophys Res Commun. 2014 Feb 7;444(2):182–188.
99. Di Y, He YL, Zhao T, et al. Methylene blue reduces acute cerebral ischemic injury via the induction of mitophagy. Mol Med. 2015;21:420–429.
100. Baek SH, Noh AR, Kim KA, et al. Modulation of mitochondrial function and autophagy mediates carnosine neuroprotection against ischemic brain damage. Stroke. 2014 Aug;45(8):2438–2443.•• Detrimental roles of excessive mitophagy.
101. Shirley R, Ord EN, Work LM. Oxidative stress and the use of antioxidants in stroke. Antioxidants (Basel). 2014;3(3):472–501.
102. Tsivgoulis G, Katsanos AH, Alexandrov AV. Reperfusion therapies of acute ischemic stroke:potentials and failures. Front Neurol. 2014;5:215.
103. Gomis M, Davalos A. Recanalization and reperfusion therapies of acute ischemic stroke:what have we learned, what are the major research questions, and where are we headed? Front Neurol. 2014;5:226.
104. Grivennikova VG, Kareyeva AV, Vinogradov AD. What are the sources of hydrogen peroxide production by heart mitochondria? Biochim Biophys Acta. 2010 Jun-Jul;1797(6–7):939–944.
105. Zuo W, Zhang S, Xia CY, et al. Mitochondria autophagy is induced after hypoxic/ischemic stress in a Drp1 dependent manner:the role of inhibition of Drp1 in ischemic brain damage. Neuropharmacology. 2014;86:103–115.
106. Wang Y, Nartiss Y, Steipe B, et al. ROS-induced mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial degradation by autophagy. Autophagy. 2012 Oct;8(10):1462–1476.
107. Wei X, Qi Y, Zhang X, et al. ROS act as an upstream signal to mediate cadmium-induced mitophagy in mouse brain. Neurotoxicology. 2015;46:19–24.
108. Li L, Tan J, Miao Y, et al. ROS and autophagy:interactions and molecular regulatory mechanisms. Cell Mol Neurobiol. 2015 Jul;35(5):615–621.• Recent review of the interactions between ROS and autophagy.
109. Bradley SA, Steinert JR. Nitric oxide-mediated posttranslational modifications:impacts at the synapse. Oxid Med Cell Longev. 2016;2016:5681036.
110. Garry PS, Ezra M, Rowland MJ, et al. The role of the nitric oxide pathway in brain injury and its treatment–from bench to bedside. Exp Neurol. 2015;263:235–243.
111. Zanini GM, Cabrales P, Barkho W, et al. Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice. J Neuroinflammation. 2011;8:66.
112. Shen J, Ma S, Chan P, et al. Nitric oxide down-regulates caveolin-1 expression in rat brains during focal cerebral ischemia and reperfusion injury. J Neurochem. 2006 Feb;96(4):1078–1089.•• Roles of NO in cerebral ischemia-reperfusion injury.
113. Sato Y, Sagami I, Shimizu T. Identification of caveolin-1-interacting sites in neuronal nitric-oxide synthase molecular mechanism for inhibition of NO formation. J Biol Chem. 2004 Mar 5;279(10):8827–8836.
114. Gu Y, Dee CM, Shen J. Interaction of free radicals, matrix metalloproteinases and caveolin-1 impacts blood-brain barrier permeability. Front Biosci (Schol Ed). 2011;3:1216–1231.
115. Gu Y, Zheng G, Xu M, et al. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. J Neurochem. 2012 Jan;120(1):147–156.
116. Fu S, Gu Y, Jiang JQ, et al. Calycosin-7-O-beta-D-glucoside regulates nitric oxide /caveolin-1/matrix metalloproteinases pathway and protects blood-brain barrier integrity in experimental cerebral ischemia-reperfusion injury. J Ethnopharmacol. 2014 Aug 8;155(1):692–701.
117. Isobe C, Abe T, Terayama Y. Remarkable increase in 3-nitrotyrosine in the cerebrospinal fluid in patients with lacunar stroke. Brain Res. 2009 Dec 11;1305:132–136.
118. Bas DF, Topcuoglu MA, Gursoy-Ozdemir Y, et al. Plasma 3-nitrotyrosine estimates the reperfusion-induced cerebrovascular stress, whereas matrix metalloproteinases mainly reflect plasma activity:a study in patients treated with thrombolysis or endovascular recanalization. J Neurochem. 2012 Nov;123(Suppl 2):138–147.• 3-NT, as a useful tool to monitor oxygen/nitrogen radicals in patients.
119. Yang D, Sun ZN, Peng T, et al. Synthetic fluorescent probes for imaging of peroxynitrite and hypochlorous acid in living cells. Methods Mol Biol. 2010;591:93–103.•• Sensitive probes for peroxynitrite detection.
120. Sena E, Wheble P, Sandercock P, et al. Systematic review and meta-analysis of the efficacy of tirilazad in experimental stroke. Stroke. 2007 Feb;38(2):388–394.
121. O’Neill MJ, Murray TK, McCarty DR, et al. ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia. Brain Res. 2000 Jul 21;871(2):234–244.
122. Perez-Asensio FJ, Hurtado O, Burguete MC, et al. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia. Neurobiol Dis. 2005 Mar;18(2):375–384.
123. Sun M, Zhao Y, Gu Y, et al. Neuroprotective actions of aminoguanidine involve reduced the activation of calpain and caspase-3 in a rat model of stroke. Neurochem Int. 2010 Mar;56(4):634–641.
124. Li Q, Atochin D, Kashiwagi S, et al. Deficient eNOS phosphorylation is a mechanism for diabetic vascular dysfunction contributing to increased stroke size. Stroke. 2013 Nov;44(11):3183–3188.
125. Chen J, Cui X, Zacharek A, et al. eNOS mediates TO90317 treatment-induced angiogenesis and functional outcome after stroke in mice. Stroke. 2009 Jul;40(7):2532–2538.
126. Ferrer-Sueta G, Radi R. Chemical biology of peroxynitrite:kinetics, diffusion, and radicals. ACS Chem Biol. 2009 Mar 20;4(3):161–177.
127. Herold S, Fago A. Reactions of peroxynitrite with globin proteins and their possible physiological role. Comp Biochem Physiol A Mol Integr Physiol. 2005 Oct;142(2):124–129.
128. Kuhn DM, Sakowski SA, Sadidi M, et al. Nitrotyrosine as a marker for peroxynitrite-induced neurotoxicity:the beginning or the end of the end of dopamine neurons? J Neurochem. 2004 May;89(3):529–536.
129. Ding R, Chen Y, Yang S, et al. Blood-brain barrier disruption induced by hemoglobin in vivo:involvement of up-regulation of nitric oxide synthase and peroxynitrite formation. Brain Res. 2014 Jul;7(1571):25–38.
130. Sun L, Yang L, Fu Y, et al. Capacity of HSYA to inhibit nitrotyrosine formation induced by focal ischemic brain injury. Nitric Oxide. 2013 Nov;30(35):144–151.
131. Yang D, Wang HL, Sun ZN, et al. A highly selective fluorescent probe for the detection and imaging of peroxynitrite in living cells. J Am Chem Soc. 2006 May 10;128(18):6004–6005.
132. Gong J, Sun F, Li Y, et al. Momordica charantia polysaccharides could protect against cerebral ischemia/reperfusion injury through inhibiting oxidative stress mediated c-Jun N-terminal kinase 3 signaling pathway. Neuropharmacology. 2015;91:123–134.
133. Gao L, Zhou Y, Zhong W, et al. Caveolin-1 is essential for protecting against binge drinking-induced liver damage through inhibiting reactive nitrogen species. Hepatology. 2014 Aug;60(2):687–699.
134. Chen HS, Chen XM, Feng JH, et al. Peroxynitrite decomposition catalyst reduces delayed thrombolysis-induced hemorrhagic transformation in ischemia-reperfused rat brains. CNS Neurosci Ther. 2015 Jul;21(7):585–590.
135. Xu M, Chen X, Gu Y, et al. Baicalin can scavenge peroxynitrite and ameliorate endogenous peroxynitrite-mediated neurotoxicity in cerebral ischemia-reperfusion injury. J Ethnopharmacol. 2013 Oct 28;150(1):116–124.
136. Yu ZF, Bruce-Keller AJ, Goodman Y, et al. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res. 1998 Sep 1;53(5):613–625.
137. Montagna C, Rizza S, Maiani E, et al. To eat, or NOt to eat:S-nitrosylation signaling in autophagy. Febs J. 2016 Nov;283(21):3857-3869.•• Extensive review of S-nitrosylation signaling in autophagy.
138. Nakamura T, Lipton SA. Protein S-Nitrosylation as a therapeutic target for neurodegenerative diseases. Trends Pharmacol Sci. 2016 Jan;37(1):73–84.
139. Nakamura T, Tu S, Akhtar MW, et al. Aberrant protein s-nitrosylation in neurodegenerative diseases. Neuron. 2013 May 22;78(4):596–614.• Roles of aberrant s-nitrosylation signaling in neurodegenerative diseases.
140. Haldar SM, Stamler JS. S-Nitrosylation at the interface of autophagy and disease. Mol Cell. 2011 Jul 8;43(1):1–3.
141. Duan L, Danzer B, Levenson VV, et al. Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells. Cancer Lett. 2014 Oct 28;353(2):290–300.
142. He H, Feng YS, Zang LH, et al. Nitric oxide induces apoptosis and autophagy; autophagy down-regulates NO synthesis in physalin A-treated A375-S2 human melanoma cells. Food Chem Toxicol. 2014;71:128–135.
143. Tripathi DN, Chowdhury R, Trudel LJ, et al. Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1. Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):E2950–7.
144. Ye YC, Wang HJ, Xu L, et al. Oridonin induces apoptosis and autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53 positive-feedback loop signaling pathway. Acta Pharmacol Sin. 2012 Aug;33(8):1055–1061.
145. Park SY, Park MY, Park HG, et al. Nitric oxide-induced autophagy and the activation of AMPK pathway protect against apoptosis in human dental pulp cells. Int Endod J. 2016 Nov;53(9):5935-5947.
146. Yang JY, Park MY, Park SY, et al. Nitric oxide-induced autophagy in mc3t3-e1 cells is associated with cytoprotection via AMPK activation. Korean J Physiol Pharmacol. 2015 Nov;19(6):507–514.
147. Han JY, Kang MJ, Kim KH, et al. Nitric oxide induction of Parkin translocation in PTEN-induced putative kinase 1 (PINK1) deficiency:functional role of neuronal nitric oxide synthase during mitophagy. J Biol Chem. 2015 Apr 17;290(16):10325–10335.
148. Sarkar S, Korolchuk VI, Renna M, et al. Complex inhibitory effects of nitric oxide on autophagy. Mol Cell. 2011 Jul 8;43(1):19–32.•• First report about the inhibitory effects of nitric oxide on autophagy.
149. Zhang L, Js C, Bahar R, et al. Interferon regulatory factor-1 regulates the autophagic response in LPS-stimulated macrophages through nitric oxide. Mol Med. 2012;18:201–208.
150. Shen C, Yan J, Erkocak OF, et al. Nitric oxide inhibits autophagy via suppression of JNK in meniscal cells. Rheumatology (Oxford). 2014 Jun;53(6):1022–1033.
151. Ishima Y, Inoue A, Fang J, et al. Poly-S-nitrosated human albumin enhances the antitumor and antimetastasis effect of bevacizumab, partly by inhibiting autophagy through the generation of nitric oxide. Cancer Sci. 2015 Feb;106(2):194–200.
152. Wright C, Iyer AK, Kulkarni Y, et al. S-Nitrosylation of bcl-2 negatively affects autophagy in lung epithelial cells. J Cell Biochem. 2016 Feb;117(2):521–532.
153. Radi R. Protein tyrosine nitration:biochemical mechanisms and structural basis of functional effects. Acc Chem Res. 2013 Feb 19;46(2):550–559.
154. Oberley TD, Swanlund JM, Zhang HJ, et al. Aging results in increased autophagy of mitochondria and protein nitration in rat hepatocytes following heat stress. J Histochem Cytochem. 2008 Jun;56(6):615–627.
155. Swanlund JM, Kregel KC, Oberley TD. Autophagy following heat stress:the role of aging and protein nitration. Autophagy. 2008 Oct;4(7):936–939.
156. Ito C, Saito Y, Nozawa T, et al. Endogenous nitrated nucleotide is a key mediator of autophagy and innate defense against bacteria. Mol Cell. 2013 Dec 26;52(6):794–804.
157. Mattart L, Calay D, Simon D, et al. The peroxynitrite donor 3-morpholinosydnonimine activates nrf2 and the UPR leading to a cytoprotective response in endothelial cells. Cell Signal. 2012 Jan;24(1):199–213.
158. Kaminskyy VO, Zhivotovsky B. Free radicals in cross talk between autophagy and apoptosis. Antioxid Redox Signal. 2014 Jul 1;21(1):86–102.
159. Lizama-Manibusan B, McLaughlin B. Redox modification of proteins as essential mediators of CNS autophagy and mitophagy. FEBS Lett. 2013 Aug 2;587(15):2291–2298.
160. Nakamura T, Prikhodko OA, Pirie E, et al. Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases. Neurobiol Dis. 2015;84:99–108.
161. Cho DH, Nakamura T, Fang J, et al. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science. 2009 Apr 3;324(5923):102–105.
162. Nakamura T, Cieplak P, Cho DH, et al. S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration. Mitochondrion. 2010 Aug;10(5):573–578.
163. Barsoum MJ, Yuan H, Gerencser AA, et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. Embo J. 2006 Aug 23;25(16):3900–3911.
164. Liu J, Weaver J, Jin X, et al. Nitric oxide interacts with caveolin-1 to facilitate autophagy-lysosome-mediated claudin-5 degradation in oxygen-glucose deprivation-treated endothelial cells. Mol Neurobiol. 2015 Oct 29. doi:10.1111/iej.12616
165. Zhu T, Yao Q, Wang W, et al. INOS induces vascular endothelial cell migration and apoptosis via autophagy in ischemia/reperfusion injury. Cell Physiol Biochem. 2016;38(4):1575–1588.
166. Peinado MA, Hernandez R, Peragon J, et al. Proteomic characterization of nitrated cell targets after hypobaric hypoxia and reoxygenation in rat brain. J Proteomics. 2014 Sep;23(109):309–321.
167. Liu B, Tewari AK, Zhang L, et al. Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury:mitochondria as the major target. Biochim Biophys Acta. 2009 Mar;1794(3):476–485.• Proteomic report of protein tyrosine nitration after ischemia-reperfusion injury.
168. Vattemi G, Mechref Y, Marini M, et al. Increased protein nitration in mitochondrial diseases:evidence for vessel wall involvement. Mol Cell Proteomics. 2011 Apr;10(4):M110 002964.
169. Yang M, Camara AK, Wakim BT, et al. Tyrosine nitration of voltage-dependent anion channels in cardiac ischemia-reperfusion:reduction by peroxynitrite scavenging. Biochim Biophys Acta. 2012 Nov;1817(11):2049–2059.
170. Teng RJ, Wu TJ, Afolayan AJ, et al. Nitrotyrosine impairs mitochondrial function in fetal lamb pulmonary artery endothelial cells. Am J Physiol Cell Physiol. 2016 Jan 1;310(1):C80–8.
171. Elfering SL, Haynes VL, Traaseth NJ, et al. Aspects, mechanism, and biological relevance of mitochondrial protein nitration sustained by mitochondrial nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2004 Jan;286(1):H22–9.
172. Han F, Chen YX, Lu YM, et al. Regulation of the ischemia-induced autophagy-lysosome processes by nitrosative stress in endothelial cells. J Pineal Res. 2011 Aug;51(1):124–135.
173. Tang YH, Ma YY, Zhang ZJ, et al. Opportunities and challenges:stem cell-based therapy for the treatment of ischemic stroke. CNS Neurosci Ther. 2015 Apr;21(4):337–347.
174. Wang Q, Duan F, Wang MX, et al. Effect of stem cell-based therapy for ischemic stroke treatment:A meta-analysis. Clin Neurol Neurosurg. 2016 Jul;146:1–11.• Recent meta-analysis of stem cell-based therapy for ischemic stroke.
175. Ansari S, Rahman M, Waters MF, et al. Recanalization therapy for acute ischemic stroke, part 1:surgical embolectomy and chemical thrombolysis. Neurosurg Rev. 2011 Jan;34(1):1–9.
176. Donnan GA, Davis SM, Parsons MW, et al. How to make better use of thrombolytic therapy in acute ischemic stroke. Nat Rev Neurol. 2011 Jul;7(7):400–409.